If you look at the last 4Q reports, RBCN has beat estimates 3 out of the last 4 quarters.
More importantly, after that brutal Q1 2014 RBCN looks to be trending up and up on the EPS since then, in Q2 and Q3 FY 2014.
How quick people forget, GTAT flooded the market with their garbage product and I believe most of it was useless. That should be all clear by now, I expect the trend to continue and for them to post a $-.33 EPS against a $-.40 forecast for the WIN.
Sapphire glass will definitely have it's day, long RBCN.
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM